#file_format=SDRF
#version=v1.1.0
#template=default
#template_version=v1.1.0
source name	characteristics[organism]	characteristics[organism part]	characteristics[ancestry category]	characteristics[age]	characteristics[developmental stage]	characteristics[sex]	characteristics[cell line]	characteristics[disease]	characteristics[cell type]	characteristics[biological replicate]	characteristics[material type]	assay name	technology type	comment[fraction identifier]	comment[technical replicate]	comment[file uri]	comment[instrument]	comment[MS2 analyzer type]	comment[label]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[proteomics data acquisition method]	comment[data file]
Sample 1	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 1	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_A1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_A1.raw
Sample 1	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 2	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_A2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_A2.raw
Sample 1	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 3	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_A3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_A3.raw
Sample 1	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 4	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_A4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_A4.raw
Sample 1	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 5	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_A5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_A5.raw
Sample 2	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 6	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_B1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_B1.raw
Sample 2	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 7	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_B2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_B2.raw
Sample 2	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 8	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_B3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_B3.raw
Sample 2	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 9	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_B4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_B4.raw
Sample 2	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 10	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_B5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_B5.raw
Sample 3	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 11	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_C1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_C1.raw
Sample 3	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 12	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_C2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_C2.raw
Sample 3	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 13	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_C3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_C3.raw
Sample 3	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 14	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_C4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_C4.raw
Sample 3	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 15	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_C5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_C5.raw
Sample 4	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 16	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_D1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_D1.raw
Sample 4	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 17	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_D2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_D2.raw
Sample 4	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 18	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_D3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_D3.raw
Sample 4	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 19	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_D4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_D4.raw
Sample 4	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 20	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_D5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_D5.raw
Sample 5	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 21	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_E1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_E1.raw
Sample 5	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 22	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_E2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_E2.raw
Sample 5	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 23	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_E3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_E3.raw
Sample 5	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 24	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_E4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_E4.raw
Sample 5	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 25	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_E5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_E5.raw
Sample 6	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 26	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_F1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_F1.raw
Sample 6	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 27	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_F2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_F2.raw
Sample 6	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 28	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_F3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_F3.raw
Sample 6	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 29	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_F4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_F4.raw
Sample 6	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 30	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_F5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_F5.raw
Sample 7	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 31	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_G1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_G1.raw
Sample 7	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 32	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_G2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_G2.raw
Sample 7	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 33	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_G3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_G3.raw
Sample 7	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 34	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_G4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_G4.raw
Sample 7	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 35	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_G5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_G5.raw
Sample 8	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 36	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_H1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_H1.raw
Sample 8	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 37	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_H2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_H2.raw
Sample 8	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 38	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_H3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_H3.raw
Sample 8	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 39	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_H4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_H4.raw
Sample 8	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 40	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_H5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_H5.raw
Sample 9	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 41	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_I1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_I1.raw
Sample 9	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 42	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_I2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_I2.raw
Sample 9	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 43	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_I3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_I3.raw
Sample 9	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 44	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_I4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_I4.raw
Sample 9	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 45	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_I5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_I5.raw
Sample 10	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 46	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_J1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_J1.raw
Sample 10	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 47	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_J2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_J2.raw
Sample 10	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 48	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_J3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_J3.raw
Sample 10	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 49	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_J4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_J4.raw
Sample 10	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 50	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_J5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_J5.raw
Sample 11	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 51	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_K1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_K1.raw
Sample 11	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 52	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_K2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_K2.raw
Sample 11	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 53	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_K3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_K3.raw
Sample 11	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 54	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_K4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_K4.raw
Sample 11	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 55	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_K5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_K5.raw
Sample 12	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 56	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_L1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_L1.raw
Sample 12	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 57	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_L2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_L2.raw
Sample 12	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 58	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_L3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_L3.raw
Sample 12	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 59	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_L4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_L4.raw
Sample 12	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 60	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_L5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_L5.raw
Sample 13	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 61	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_M1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_M1.raw
Sample 13	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 62	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_M2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_M2.raw
Sample 13	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 63	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_M3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_M3.raw
Sample 13	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 64	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_M4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_M4.raw
Sample 13	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 65	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_M5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_M5.raw
Sample 14	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 66	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_N1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_N1.raw
Sample 14	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 67	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_N2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_N2.raw
Sample 14	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 68	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_N3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_N3.raw
Sample 14	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 69	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_N4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_N4.raw
Sample 14	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 70	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_N5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_N5.raw
Sample 15	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 71	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_O1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_O1.raw
Sample 15	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 72	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_O2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_O2.raw
Sample 15	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 73	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_O3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_O3.raw
Sample 15	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 74	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_O4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_O4.raw
Sample 15	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 75	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_O5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_O5.raw
Sample 16	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 76	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_P1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_P1.raw
Sample 16	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 77	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_P2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_P2.raw
Sample 16	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 78	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_P3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_P3.raw
Sample 16	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 79	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_P4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_P4.raw
Sample 16	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 80	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_P5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_P5.raw
Sample 17	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 81	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_Q1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_Q1.raw
Sample 17	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 82	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_Q2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_Q2.raw
Sample 17	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 83	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_Q3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_Q3.raw
Sample 17	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 84	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_Q4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_Q4.raw
Sample 17	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 85	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_Q5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_Q5.raw
Sample 18	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 86	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_R1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_R1.raw
Sample 18	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 87	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_R2.raw
Sample 18	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 88	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_R3.raw
Sample 18	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 89	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_R4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_R4.raw
Sample 18	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 90	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_R5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_R5.raw
Sample 19	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 91	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_S1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_S1.raw
Sample 19	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 92	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_S2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_S2.raw
Sample 19	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 93	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_S3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_S3.raw
Sample 19	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 94	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_S4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_S4.raw
Sample 19	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 95	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_S5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_S5.raw
Sample 20	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 96	proteomic profiling by mass spectrometry	1	1	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_T1.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_T1.raw
Sample 20	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 97	proteomic profiling by mass spectrometry	1	2	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_T2.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_T2.raw
Sample 20	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 98	proteomic profiling by mass spectrometry	1	3	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_T3.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_T3.raw
Sample 20	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 99	proteomic profiling by mass spectrometry	1	4	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_T4.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_T4.raw
Sample 20	Homo sapiens	pancreas	not available	64Y	adult	not available	not available	pancreatic ductal adenocarcinoma (PDAC)	not available	1	tissue	run 100	proteomic profiling by mass spectrometry	1	5	https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/09/PXD015744/QE1_180417_OPL1022_TLL_PDAC_tumor_T5.raw	NT=Q Exactive;AC=MS:1001911	NT=Orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Any N-term;AC=UNIMOD:1;MT=Variable	HCD	25 NCE	4.5 ppm	20 ppm	NT=Data-dependent acquisition;AC=PRIDE:0000627	QE1_180417_OPL1022_TLL_PDAC_tumor_T5.raw
